AI is transforming oncology by enhancing clinical trials, personalizing treatments, and improving pharmacy practices, promising faster, more precise cancer care.
Paul Alebrande, PharmD Candidate
Advertisement
Articles by Paul Alebrande, PharmD Candidate
Artificial intelligence (AI) is rapidly transforming oncology by enhancing clinical trial design, streamlining patient recruitment, improving precision medicine, and optimizing pharmacy operations, while raising important challenges around data ethics, bias, and integration into clinical workflows.
Advertisement
Latest Updated Articles
Harnessing AI to Advance Clinical Trials and Oncology PharmacyPublished: August 4th 2025 | Updated:
Harnessing AI to Streamline Clinical Trials, Optimize Pharmacy, and Personalize Cancer TreatmentPublished: July 23rd 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
FDA Approves Imlunestrant Tablets for ER+, HER2–, ESR1-Mutated Advanced or Metastatic Breast Cancer
2
IMWG Consensus Risk Criteria Predicts Survival in Daratumumab Quadruplet Therapy
3
Linvoseltamab Monotherapy Elicits Promising ORR, MRD-Negativity in NDMM
4
How Pharmacists Support CDK4/6 Inhibitor Management and Patient Care
5
